Growth Metrics

BioLineRx (BLRX) Leases (2019 - 2025)

BioLineRx (BLRX) posted Leases of $696000.0 for Q4 2025, down 3.87% on a QoQ basis from $724000.0 in Q3 2025, and down 28.02% year-over-year from $967000.0 in Q4 2024.

BioLineRx (BLRX) has 7 years of Leases data on file, last reported at $696000.0 in Q4 2025.

  • In Q4 2025, Leases fell 28.02% year-over-year to $696000.0; the TTM figure through Dec 2025 stood at $696000.0 (down 28.02% YoY), while the FY2025 annual figure was $696000.0, down 28.02% from the prior year.
  • Leases fell to $696000.0 in Q4 2025, from $724000.0 in the prior quarter.
  • Across five years, Leases topped out at $1.8 million in Q4 2022 and bottomed at $696000.0 in Q4 2025.
  • A 5-year average of $1.3 million and a median of $1.3 million in 2021 frame the typical range for Leases.
  • Annual changes were most pronounced in 2022 — Leases surged 33.13% — and 2025, when it plunged 48.21%.
  • Year by year, Leases stood at $1.3 million in 2021, then jumped by 33.13% to $1.8 million in 2022, then declined by 20.15% to $1.4 million in 2023, then slumped by 31.66% to $967000.0 in 2024, then decreased by 28.02% to $696000.0 in 2025.
  • The last three Leases figures came in at $696000.0 (Q4 2025), $724000.0 (Q3 2025), and $800000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 61,822.50
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 189.30 Mn
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 696,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 696,000.00
Sep 30, 2025 724,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 863,000.00
Dec 31, 2024 967,000.00
Sep 30, 2024 1.40 Mn
Jun 30, 2024 1.45 Mn
Mar 31, 2024 1.31 Mn
Dec 31, 2023 1.42 Mn
Sep 30, 2023 1.46 Mn
Jun 30, 2023 1.58 Mn
Mar 31, 2023 1.69 Mn
Dec 31, 2022 1.77 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.22 Mn
Mar 31, 2022 1.27 Mn
Dec 31, 2021 1.33 Mn
Sep 30, 2021 1.34 Mn
Jun 30, 2021 1.42 Mn
Mar 31, 2021 1.30 Mn
Dec 31, 2020 1.36 Mn
Sep 30, 2020 1.42 Mn
Jun 30, 2020 1.49 Mn
Mar 31, 2020 1.57 Mn
Dec 31, 2019 1.65 Mn
Sep 30, 2019 1.64 Mn
Jun 30, 2019 1.72 Mn
Mar 31, 2019 1.80 Mn